upon achieving complete remissions with daunorubicin plus cytosine arabinoside , 14 patients were randomized to receive either : regimen a -- cytosine arabinoside , 6-thioguanine , plus bcg each month ;
C0280573
daunorubicin
C0010711
cytosine